Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Quarterly results
Inv. presentation
Auditor change
Appointed director

IMMUNOMEDICS INC (IMMU) Create: Alert

All | News | Filings
Date FiledTypeDescription
02/16/2021 SC 13G/A Point72 Asset Management, L.P. reports a 0% stake in Immunomedics, Inc.
11/09/2020 SC 13G/A BlackRock Inc. reports a 0% stake in IMMUNOMEDICS INC
11/02/2020 15-12G Form 15-12G - Securities registration termination [Section 12(g)]:
10/30/2020 EFFECT Form EFFECT - Notice of Effectiveness:
10/30/2020 EFFECT Form EFFECT - Notice of Effectiveness:
10/30/2020 EFFECT Form EFFECT - Notice of Effectiveness:
10/27/2020 4 Fricker William (Principal Accounting Officer) has filed a Form 4 on IMMUNOMEDICS INC
Txns: Disposed/sold 65,310 options to buy @ $0
10/23/2020 4 Aghazadeh Behzad (10% Owner) has filed a Form 4 on IMMUNOMEDICS INC
Txns: Disposed/sold 13,516 shares @ $0
Disposed/sold 26,250,000 shares @ $0
Disposed/sold 202,614 options to buy @ $0
Disposed/sold 103,718 restricted stock units @ $0
10/23/2020 4 Malik Usama (Chief Fin. & Business Officer) has filed a Form 4 on IMMUNOMEDICS INC
Txns: Disposed/sold 18,856 shares @ $0
Disposed/sold 386,080 options to buy @ $0
10/23/2020 4 Canute Scott A (Director) has filed a Form 4 on IMMUNOMEDICS INC
Txns: Disposed/sold 13,516 shares @ $0
Disposed/sold 155,286 options to buy @ $0
Disposed/sold 3,718 restricted stock units @ $0
10/23/2020 4 Azelby Robert (Director) has filed a Form 4 on IMMUNOMEDICS INC
Txns: Disposed/sold 29,040 options to buy @ $0
Disposed/sold 3,718 restricted stock units @ $0
10/23/2020 4 HUTT PETER BARTON (Director) has filed a Form 4 on IMMUNOMEDICS INC
Txns: Disposed/sold 13,516 shares @ $0
Disposed/sold 52,614 options to buy @ $0
Disposed/sold 3,718 restricted stock units @ $0
10/23/2020 4 ITRI LORETTTA M (Chief Medical Officer) has filed a Form 4 on IMMUNOMEDICS INC
Txns: Disposed/sold 15,000 shares @ $0
Disposed/sold 200,000 options to buy @ $0
10/23/2020 4 Andrews Kurt J. (Chief Human Resources Officer) has filed a Form 4 on IMMUNOMEDICS INC
Txns: Disposed/sold 238,072 options to buy @ $0
10/23/2020 4 Islam Khalid (Director) has filed a Form 4 on IMMUNOMEDICS INC
Txns: Disposed/sold 13,516 shares @ $0
Disposed/sold 52,614 options to buy @ $0
Disposed/sold 3,718 restricted stock units @ $0
10/23/2020 4 BALL BRYAN (Chief Quality Officer) has filed a Form 4 on IMMUNOMEDICS INC
Txns: Disposed/sold 10,000 shares @ $0
Disposed/sold 261,937 options to buy @ $0
10/23/2020 4 Freedberg Jared (Gen. Counsel & Corp. Secretary) has filed a Form 4 on IMMUNOMEDICS INC
Txns: Disposed/sold 280,105 options to buy @ $0
10/23/2020 4 Delaney Brendan (Chief Commercial Officer) has filed a Form 4 on IMMUNOMEDICS INC
Txns: Disposed/sold 390,460 options to buy @ $0
10/23/2020 4 BAUM CHARLES M (Director) has filed a Form 4 on IMMUNOMEDICS INC
Txns: Disposed/sold 9,667 shares @ $0
Disposed/sold 46,117 options to buy @ $0
Disposed/sold 3,718 restricted stock units @ $0
10/23/2020 4 Duncan Barbara Gayle (Director) has filed a Form 4 on IMMUNOMEDICS INC
Txns: Disposed/sold 49,244 shares @ $0
Disposed/sold 6,540 options to buy @ $0
Disposed/sold 3,718 restricted stock units @ $0
10/23/2020 SC 13D/A venBio Select Advisor LLC reports a 0% stake in Immunomedics, Inc.
10/23/2020 POS AM Form POS AM - Post-Effective amendments for registration statement:
10/23/2020 POS AM Form POS AM - Post-Effective amendments for registration statement:
10/23/2020 POS AM Form POS AM - Post-Effective amendments for registration statement:
10/23/2020 POS AM Form POS AM - Post-Effective amendments for registration statement:
10/23/2020 POS AM Form POS AM - Post-Effective amendments for registration statement:
10/23/2020 POS AM Form POS AM - Post-Effective amendments for registration statement:
10/23/2020 POS AM Form POS AM - Post-Effective amendments for registration statement:
10/23/2020 8-K Resignation/termination of a director
Docs: "Amended and Restated Certificate of Incorporation of Immunomedics, Inc",
"Amended and Restated Bylaws of Immunomedics, Inc"
10/23/2020 25-NSE Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities:
10/23/2020 SC 14D9/A Form SC 14D9/A - Solicitation, recommendation statements: [Amend]
10/23/2020 SC TO-T/A Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
10/14/2020 SC TO-T/A Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
10/14/2020 SC 14D9/A Form SC 14D9/A - Solicitation, recommendation statements: [Amend]
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy